Okogen to receive over $10mn from MRCF through Series A funding

Date: 2018-03-01   Author: Saipriya Iyer  Category: #market

Okogen to receive over $10mn from MRCF through Series A funding

Brandon Capital’s Medical Research Commercialization Fund (MRCF), one of the biggest life science investment fund firms in New Zealand & Australia, has reportedly made investments worth USD 10 million in Okogen Inc., a biotech firm developing ophthalmic anti-effective medicines, in its Series A funding. As per sources, the funds are expected to assist Okogen in developing OKG 0301, a leading candidate for viral conjunctivitis.

For the uninitiated, adenoviral conjunctivitis is one of the main causes of eye infection across the globe. With no approved treatments, unmet medical needs of patients are rampant across the globe. Researchers have been testing the ability of OKG-0301, an effective ribonuclease with proven antiviral characteristics, to treat viral conjunctivitis in the patients by conducting Phase 2 clinical trials before 2018.

Incidentally, OKG-0301 is currently undergoing clinical development, and with MRCF’s funds, the commencement of the Phase II clinical trial for OKG-0301 will be onboard in 2018. As per reports, nearly 30 million cases of acute conjunctivitis occur yearly across the globe, which includes approximately 6 million of the U.S. population. Around 70% of the U.S. population is treated for acute conjunctivitis every year, and 80% of these patients are diagnosed with viral forms of the infection.

The CEO of Okogen Inc., has announced that safe & effective therapies are required to treat highly infectious ailments such as conjunctivitis and OKG-0301 has the clinical & commercial potential to treat the same. He further added that the Series A funding by Brandon Capital will help the firm in exploring new opportunities across the biopharmaceutical sector.

MRCF’s Investment Manager has also reaffirmed his faith in Okogen by stating that the funding will help in making Okogen’s technology stronger and equip the same with the potential of bringing a positive change in the lives of many patients.



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Rugged Laptop Computers Size 2020 by Product, Revenue, Price, Industry Share, Growth Opportunity and Forecast to 2025 Research Report by MSR

Author: Ashwin Naphade

The Rugged Laptop Computers market research report delivers crucial analysis of the major trends, risks, and opportunities likely to impact the remuneration scale and CAGR of this business sphere, alongside impact of COVID-19.

The busine...


Diesel Temporary Power Market Global Production, Growth, Share, Demand and Applications Forecast to 2025

Author: Ashwin Naphade

The Diesel Temporary Power market report consists of vital data pertaining to the CAGR, remuneration scale, drivers, restraints, COVID-19 impact, products, applications, and competitive outlook of this business domain.

The business intel...


Radio Frequency Market Size, Detail Analysis for Business Development, Top Companies 2025

Author: Ashwin Naphade

Radio Frequency market to grow substantially during 2020-2025. The research report entails valuable and essential data on industry size, trends, growth drivers, restraints, forecasts, and Covid-19 impact.

The business intelligence report...